Connect with us
In the last quarter of 2020, Fresenius Helios Spain's revenues were $1.2 billion (€999 million), 15% more than in the same period of 2019. In the...
The total shareholder return in 2020 was 19.3% in CHF and 18.1% in EUR, slightly below the performance of the underlying portfolio. In addition to Mersana...
The volume of mergers and acquisitions in the pharmaceutical and healthcare sector increased by 25% compared to the first half of the year. Excluding the mega-deals,...
At the moment, Corify Care has conducted a prevalidation of its equipment with 200 patients. Acorys is a non-invasive smart cardiac mapping system, which combines high-density...
Minoryx has completed a Phase 3 trial with its drug candidate for a neurodegenerative orphan disease and the results are significant. The only downside is that...
The combined profit of Pfizer, Roche, Johnson&Johnson (J&J), Sanofi, Merck and Novartis exceeds $70.52 billion (€58 billion) in 2020. Sanofi achieved a profit of $16.06 billion...
AurorA Science had led its first investment last December 2020, participating in the $13.8 million (€11.4 million) round from Spanish biotech Peptomyc. AurorA recently invested in...
The Generalitat awards Werfen the delivery of reagents at the Vall d'Hebron for up to $959,000 (€791,000). The Barcelona-based company is committed to offer this service...
The life sciences venture capital fund, Altamar, added five companies to its portfolio in 2020 and continued to invest in two others. In 2021, Alta LS...
While on the one hand, the company Roche had a very good year in 2020, on the other hand, it was affected by the corona crisis.Thus,...
 |
|
 |  |
 |
|